Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

The first biomarker-based cervical cancer screening test, p16/Ki-67 dual-stained cytology (DS), has been clinically validated and approved in the United States for triage of women being screened for cervical cancer who test positive for high-risk human papillomavirus (hrHPV). The primary aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Harper, Diane M., Anderson, Rye J., Baker, Ed, Yu, Tiffany M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320467/
https://www.ncbi.nlm.nih.gov/pubmed/37210751
http://dx.doi.org/10.1158/1940-6207.CAPR-22-0455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320467/
https://www.ncbi.nlm.nih.gov/pubmed/37210751
http://dx.doi.org/10.1158/1940-6207.CAPR-22-0455

Ejemplares similares